Rheumatoid Arthritis Clinical Trials in Chicago

Showing 1881-1900 of 3,890 trials

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

NCT01696461

This is a Phase II, open-label, two strata, multicenter, prospective study of plerixafor-mobilized HLA-identical sibling allografts in recipients with hematological malignancies. This study will establish the safety and efficacy of subcutaneous plerixafor for this purpose.

Center for International Blood and Marrow Transplant Research127 participantsStarted May 2013

Tampa, Florida, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +9 more locations

TERMINATEDPhase 22.2 miles

A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair.

NCT05293522

This study involves the use of an Investigational Product called NTX-001. It is a product used in the repair of nerve injuries. It is used in the operating room. The main purposes of this study are to 1) see how safe NTX-001 is when used in nerve repair and, 2) see if your nerve becomes functional in a shorter period of time when compared to what is normally done to treat nerve injuries.

Facial Paralysis

Neuraptive Therapeutics Inc.2 participantsStarted Jul 2022

Chicago, Illinois, United States • Indianapolis, Indiana, United States • St Louis, Missouri, United States +3 more locations

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair.

Rheumatoid Arthritis Trials in Other Cities

Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Single vs Multi-fraction SRS Patients on Immunotherapy

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma

Maximizing Outcomes in Treating Acute Migraine

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient

Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence

Pain Management Following Sinus Surgery

Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses

Human Epilepsy Project 2: Resistant Focal Seizures Study

PEP on a Skin Graft Donor Site Wound

Arimoclomol in Amyotropic Lateral Sclerosis

Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis

Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD

Other Conditions in Chicago